Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Mells

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Alimentary Pharmacology & Therapeutics|December 19, 2019
Editorial: rapid assessment of health-related quality of life in primary biliary cholangitis-no excuse not to ask. Authors' replyLaith Alrubaiy, George Mells, Steven Flack, et al.
Alimentary Pharmacology & Therapeutics|October 31, 2019
PBC-10: a short quality of life measure for clinical screening in primary biliary cholangitisLaith Alrubaiy, George Mells, Steven Flack, et al.
Journal of Hepatology|April 24, 2013
A validated clinical tool for the prediction of varices in PBC: the Newcastle Varices in PBC ScoreImran Patanwala, Peter McMeekin, Ruth Walters, et al.
Cell Cycle (Georgetown, Tex.)|March 15, 2014
Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver diseaseAloysious Aravinthan, George Mells, Michael Allison, et al.
Canadian Journal of Gastroenterology & Hepatology|December 16, 2022
Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis?Aaron Wetten, Laura Ogle, George Mells, et al.
Journal of Autoimmunity|August 19, 2018
Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cellsEvaggelia Liaskou, Samita R Patel, Gwilym Webb, et al.
Hepatology (Baltimore, Md.)|April 18, 2018
The Impact of Autoimmune Hepatitis and Its Treatment on Health UtilityLin Lee Wong, Holly F Fisher, Deborah D Stocken, et al.
Cureus|June 10, 2022
The National Audit of Primary Biliary Cholangitis (PBC) in the United Kingdom: Defining the Audit Dataset and Data Collection SystemLaura Burke, Steve Flack, Rebecca Jones, et al.
Frontline Gastroenterology|February 23, 2023
UK-PBC National Audit: a collaborative success in identifying critical shortfallsLaura Burke, Steven Flack, Rebecca L Jones, et al.
Alimentary Pharmacology & Therapeutics|September 22, 2025
Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary CholangitisNadir Abbas, Rachel Smith, Ellina Lytvyak, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Alimentary Pharmacology & Therapeutics|December 19, 2019
Editorial: rapid assessment of health-related quality of life in primary biliary cholangitis-no excuse not to ask. Authors' replyLaith Alrubaiy, George Mells, Steven Flack, et al.
Alimentary Pharmacology & Therapeutics|October 31, 2019
PBC-10: a short quality of life measure for clinical screening in primary biliary cholangitisLaith Alrubaiy, George Mells, Steven Flack, et al.
Journal of Hepatology|April 24, 2013
A validated clinical tool for the prediction of varices in PBC: the Newcastle Varices in PBC ScoreImran Patanwala, Peter McMeekin, Ruth Walters, et al.
Cell Cycle (Georgetown, Tex.)|March 15, 2014
Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver diseaseAloysious Aravinthan, George Mells, Michael Allison, et al.
Canadian Journal of Gastroenterology & Hepatology|December 16, 2022
Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis?Aaron Wetten, Laura Ogle, George Mells, et al.
Journal of Autoimmunity|August 19, 2018
Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cellsEvaggelia Liaskou, Samita R Patel, Gwilym Webb, et al.
Hepatology (Baltimore, Md.)|April 18, 2018
The Impact of Autoimmune Hepatitis and Its Treatment on Health UtilityLin Lee Wong, Holly F Fisher, Deborah D Stocken, et al.
Cureus|June 10, 2022
The National Audit of Primary Biliary Cholangitis (PBC) in the United Kingdom: Defining the Audit Dataset and Data Collection SystemLaura Burke, Steve Flack, Rebecca Jones, et al.
Frontline Gastroenterology|February 23, 2023
UK-PBC National Audit: a collaborative success in identifying critical shortfallsLaura Burke, Steven Flack, Rebecca L Jones, et al.
Alimentary Pharmacology & Therapeutics|September 22, 2025
Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary CholangitisNadir Abbas, Rachel Smith, Ellina Lytvyak, et al.
Pageof 4